Skip to main content

Day: July 24, 2020

Correction: Udlodning af acontoudbytte

Bestyrelsen i Kapitalforeningen Accunia Invest har godkendt nedennævnte udbytter for andet kvartal af 2020.De optjente udbytter er vist i nedenstående tabel. Tallene er opgjort i kr. pr. investeringsbevis.Automatisk geninvestering – For automatisk geninvestering skal investor kontakte sin egen depotbank. Geninvesteringskurserne fastsættes og gennemføres til indre værdier per den 28. juli 2020 fratrukket udbytte.Tidsplan27. juli 2020 – Sidste dag for handel med beviser inkl. udbytte28. juli 2020 – Udbyttet fragår, og investeringsbeviserne handles uden udbytte30. juli 2020  – Udbyttet er til disposition på investors kontoKontaktperson(er):Direktør Caspar Møller, tlf. +45 3332 7070.Yderligere oplysninger om Kapitalforeningen Accunia Invest findes på www.accunia.com.

Continue reading

Protara Therapeutics Announces Appointment of Barry P. Flannelly to Board of Directors

NEW YORK, July 24, 2020 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced the appointment of Barry P. Flannelly, Pharm.D, to its Board of Directors. Dr. Flannelly, who currently serves as Executive Vice President, General Manager, North America, at Incyte, brings to Protara over 20 years of commercial and business development leadership experience across numerous leading pharmaceutical and biotech companies. Dr. Flannelly will replace Scott Braunstein, M.D., who resigned from the Board to focus on his role as Chief Executive Officer at Marinus Pharmaceuticals.“It is a pleasure to welcome Barry to our Board of Directors at this exciting juncture for Protara as we continue to advance our diverse...

Continue reading

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture Begins Shipping Branded Products to Manitoba

Pure Sunfarms remains top-selling dried cannabis brand with Ontario Cannabis Store1 and achieves sales records in JulyVANCOUVER, July 24, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has begun shipping branded, packaged dried flower products to Manitoba’s licensed private sector retailers, with these products available at the first 26 participating retailers in Manitoba beginning this week.Pure Sunfarms’ products are now available in five of Canada’s six most populous provinces, representing more than 70% of the Canadian population. Manitoba ranks as the sixth largest Canadian province by cannabis sales, comprising approximately 4.5% of the country’s total sales...

Continue reading

AS Tallinna Vesi will hold an Investor Conference Webinar to introduce the results for the second quarter of 2020

AS Tallinna Vesi invites its shareholders, investors, analysts and other stakeholders to join its investor conference webinar, introducing the results for the first six months of 2020. The webinar is scheduled for 31 July 2020 at 3:00 pm (EET) and will be held in English.The webinar will be hosted by the Chairman of the Board Karl Heino Brookes and Chief Financial Officer Kristi Ojakäär. The questions will be answered by Karl Heino Brookes and Kristi Ojakäär after the presentation. We encourage participants to send their questions before the webinar to eliis.randver@tvesi.ee.To join the webinar, please register via following link: https://attendee.gotowebinar.com/register/2613420800373947918. The registration is open until 31 July at 2:00 pm (EET). When joining the webinar for the first time, you will be asked to download the plug-in...

Continue reading

AS Tallinna Vesi korraldab 2020. aasta teise kvartali tulemuste tutvustamiseks veebiseminari

Tallinna Vesi kutsub aktsionäre, investoreid, analüütikuid ning teisi huvilisi osalema ettevõtte 2020. aasta esimese kuue kuu tulemusi tutvustaval veebiseminaril 31. juulil 2020 kell 15.00. Veebiseminar toimub inglise keeles.Tulemusi tutvustavad juhatuse esimees Karl Heino Brookes ning finantsdirektor Kristi Ojakäär. Karl Heino Brookes ning Kristi Ojakäär vastavad küsimustele pärast presentatsiooni. Soovitame küsimused saata enne veebiseminari toimumist e-kirja teel: eliis.randver@tvesi.ee.Veebiseminaril osalemiseks palume registreeruda hiljemalt 31. juulil kell 14.00, siin: https://attendee.gotowebinar.com/register/2613420800373947918. Teile saadetakse link veebiseminarile ning juhised keskkonna kasutamiseks. Kui osalete veebiseminaril esimest korda, palutakse alla laadida vajalik rakendus. Juhul kui rakenduse allalaadimine ei õnnestu,...

Continue reading

ScoutCam Announced Acceptance of $2.4M Quote from a Fortune 500 Multinational Healthcare Corporation

Following Acceptance of $2.4M Quote, Preeminent Visual Solutions Creator will Develop Customized Products for Medical Supplies GiantOMER, Israel , July 24, 2020 (GLOBE NEWSWIRE) — ScoutCam (OTC: SCTC), a leading developer and manufacturer of customized visual solutions and supplementary technologies, today announced the acceptance of ScoutCam’s $2.4 million quote from a Fortune 500 multinational healthcare corporation. According to the terms of this commitment, the two companies will work together to develop a complete visualization solution that incorporates ScoutCam’s single-use miniature video cameras for a minimally invasive surgical end-user product.Today’s announcement was preceded by the signing of a Development Strategy Agreement in November 2019, which will continue to govern the remainder of the existing engagement...

Continue reading

Altra Reports Second-Quarter 2020 Results

Q2 Financial Performance Exceeds Sales and Profitability ExpectationsProactive Cost Management Supports Strong Operating Cash FlowReduced Debt by $24 Million; Repaid 100% of Revolving Credit LineRaises 2020 GuidanceBRAINTREE, Mass., July 24, 2020 (GLOBE NEWSWIRE) — Altra Industrial Motion Corp. (Nasdaq: AIMC) (“Altra” or the “Company”), a leading global manufacturer and supplier of motion control, power transmission and automation products, today announced unaudited financial results for the second-quarter ended June 30, 2020.Q2 Financial HighlightsSecond-quarter 2020 net sales were $400.8 million compared with $466.5 million in the second-quarter of 2019. Second-quarter 2020 organic sales were down 12.5% compared with the second-quarter of 2019. Excluding the impact of foreign currency translation, Power Transmission Technologies...

Continue reading

ChannelAdvisor Announces Preliminary Financial Results for Second Quarter 2020, Acquisition of Brand Analytics Firm BlueBoard

Expects Record Revenue and Adjusted EBITDA to Substantially Exceed Prior GuidanceAcquisition of BlueBoard Accelerates Capabilities for BrandsFull Second Quarter 2020 Financial Results to be Announced on August 6, 2020RESEARCH TRIANGLE PARK, N.C., July 24, 2020 (GLOBE NEWSWIRE) — ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions, today announced preliminary estimated financial results for the second quarter of 2020.Based on information available as of today, total revenue is expected to be approximately $37.3 million, or $4.8 million above the previous guidance of $32.5 million, representing growth of approximately 17% compared to the second quarter of 2019. Adjusted EBITDA, a non-GAAP measure, is expected to be approximately $11.4 million, or $5.4 million above the previous guidance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.